FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eng, C.
Right arrow Articles by Ponder, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eng, C.
Right arrow Articles by Ponder, B. A.

The FASEB Journal, Vol 7, 910-919, Copyright © 1993 by The Federation of American Societies for Experimental Biology

REVIEWS

The role of gene mutations in the genesis of familial cancers

C Eng and BA Ponder
CRC Human Cancer Genetics Research Group, University of Cambridge, United Kingdom.

The simplest molecular mechanism of hereditary tumorigenesis is represented by retinoblastoma (RB). Knudson's model specifies that, in hereditary RB, the first mutation in an allele of the RB gene exists in the germline. A subsequent somatic mutation in the second normal RB allele releases RB formation in the eye. This mechanism of loss of function of both normal tumor suppressor gene copies applies to other hereditary cancer syndromes as well, including multiple endocrine neoplasia type 1, neurofibromatosis type 2, Li-Fraumeni syndrome, and probably familial breast/ovarian syndrome. In some syndromes, e.g. familial adenomatous polyposis and multiple endocrine neoplasia type 2, the mechanism may be slightly different. Loss of function of only one allele of the susceptibility locus appears to be sufficient to promote a proliferative advantage in target tissues. In many of these inherited cancer syndromes, variable expression and variable penetrance of phenotypes exist. Allelism, existence of a multigene complex, or modulation of expression by modifier genes may explain the phenomena.


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
J. Lausen, H. Thomas, I. Lemm, M. Bulman, M. Borgschulze, A. Lingott, A. T. Hattersley, and G. U. Ryffel
Naturally occurring mutations in the human HNF4{alpha} gene impair the function of the transcription factor to a varying degree
Nucleic Acids Res., January 15, 2000; 28(2): 430 - 437.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
R Nabbout, M Santos, Y Rolland, O Delalande, O Dulac, and C Chiron
Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis
J. Neurol. Neurosurg. Psychiatry, March 1, 1999; 66(3): 370 - 375.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. J. Marsh, Z. Zheng, A. Arnold, S. D. Andrew, D. Learoyd, A. Frilling, P. Komminoth, H. P.H. Neumann, B. A.J. Ponder, B. J. Rollins, et al.
Mutation Analysis of Glial Cell Line-Derived Neurotrophic Factor, a Ligand for an RET/Coreceptor Complex, in Multiple Endocrine Neoplasia Type 2 and Sporadic Neuroendocrine Tumors
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3025 - 3028.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. Eng
The RET Proto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
N. Engl. J. Med., September 26, 1996; 335(13): 943 - 951.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by The Federation of American Societies for Experimental Biology.